CHEBI:141168 - α-Neup5Gc-(2→3)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer

Main ChEBI Ontology Automatic Xrefs Reactions Pathways Models
ChEBI Name α-Neup5Gc-(2→3)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer
ChEBI ID CHEBI:141168
ChEBI ASCII Name alpha-Neup5Gc-(2->3)-beta-D-Galp-(1->4)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
Definition A sialotetraosylceramide consisting of a linear pentasaccharide made up from one N-glycoloylneuraminic acid residue, two galactose residues, one N-acetylgalactosamine residue and a glucose residue at the reducing end attached to the ceramide portion via a β-linkage.
Stars This entity has been manually annotated by the ChEBI Team.
Secondary ChEBI IDs CHEBI:62831
Download Molfile XML SDF
more structures >>
Formula C56H96N3O32R
Net Charge 0
Average Mass (excl. R groups) 1323.365
Monoisotopic Mass (excl. R groups) 1322.59769
SMILES O([C@@H]1[C@H]([C@H](O[C@H]2[C@@H]([C@H]([C@@H](O[C@@H]2CO)O[C@@H]3[C@H]([C@@H](O[C@@H]([C@@H]3O)CO)O[C@@H]4[C@H](O[C@@H](OC[C@@H]([C@@H](/C=C/CCCCCCCCCCCCC)O)NC(=O)*)[C@@H]([C@H]4O)O)CO)O)NC(C)=O)O)O[C@@H]([C@@H]1O)CO)O)[C@]5(O[C@]([C@@H]([C@H](C5)O)NC(CO)=O)([C@@H]([C@@H](CO)O)O)[H])C(O)=O
ChEBI Ontology
Outgoing α-Neup5Gc-(2→3)-β-D-Galp-(1→4)-β-D-GlcpNAc-(1→3)-β-D-Galp-(1→4)-β-D-Glcp-(1↔1')-Cer (CHEBI:141168) is a sialotetraosylceramide (CHEBI:36543)
IUPAC Names
(2S,3R,4E)-2-acylamino-3-hydroxyoctadec-4-en-1-yl 3,5-dideoxy-5-(2-hydroxyacetamido)-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranoside
(2S,3R,4E)-2-acylamino-3-hydroxyoctadec-4-en-1-yl 3,5-dideoxy-5-(glycoloylamino)-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→3)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-galactopyranosyl-(1→3)-β-D-galactopyranosyl-(1→4)-β-D-glucopyranoside
Synonyms Sources
(Gal)2 (Glc)1 (GlcNAc)1 (Neu5Gc)1 (Cer)1 KEGG GLYCAN
3'-LM1-NeuGc KEGG GLYCAN
α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1')-ceramide ChEBI
α-N-glycoloylneuraminosyl-(2→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosylceramide ChEBI
α-N-glycoloylneuraminyl-2,3-β-D-galactosyl-1,4-N-acetyl-β-D-glucosaminyl-1,3-β-D-galactosyl-1,4-β-D-glucosylceramide ChEBI
α-Neu5Gc-(2→3)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1')-Cer ChEBI
α-Neu5Gc-(2→3)-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-Cer ChEBI
HD5 ChEBI
IV3NeuGcα-nLc4Cer ChEBI
Neu5Gc(α2-3)Gal(β1-4)GlcNAc(β1-3)Gal(β1-4)Glc(β1-1)Cer ChEBI
Neu5Gcα2-3Galβ1-4GlcNAcβ1-3Galβ1-4Glcβ1-1Cer ChEBI
NeuGc-nLcOSe4Cer ChEBI
sialosylneolactotetraosylceramide (NeuGc) ChEBI
Manual Xref Database
G00332 KEGG GLYCAN
View more database links
Citations Waiting for Citations Types Sources
1379980 PubMed citation Europe PMC
1567198 PubMed citation Europe PMC
2449247 PubMed citation Europe PMC
3323577 PubMed citation Europe PMC
6204642 PubMed citation Europe PMC
Last Modified
11 October 2018